Loading...
Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA
Zarxio (filgrastim-sndz), a biosimilar for the treatment of severe chronic neutropenia
Saved in:
| Published in: | P T |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MediMedia USA, Inc.
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215272/ https://ncbi.nlm.nih.gov/pubmed/28090158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|